Delivery Order SPE2DR25D2101-SPE2DR26F46KD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $2,872.47 on September 23, 2025. The order covers Lantus SoloStar 100 Unit/mL insulin in 3mL quantities and will be performed at the contractor's Conshohocken facility with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ML quantities, with a ceiling value of $1,026.67. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a discrete task under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,237.50 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on November 25, 2025, with an ultimate completion date of November 26, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $1,952.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 unit/mL insulin in 3mL quantities, with a completion date of November 13, 2025. This non-set-aside competitive award was issued on November 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin on June 11, 2025, with a ceiling value of $1,917.75. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of June 12, 2025. This delivery order represents a small-value pharmaceutical...
- The Defense Logistics Agency awarded a $1,022.80 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin, a 3mL pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on November 7, 2025, with an ultimate completion date of November 10, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of routine pharmaceutical replenishment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,620.60 to supply Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities, with an ultimate completion date of November 12, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This $1,022.80 firm fixed-price contract represents a single delivery order with an ultimate completion date of October 24, 2025. The award was not set-aside and was competitively awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,298.48 to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This firm fixed-price delivery order, which has an ultimate completion date of November 13, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $1,968.89 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46KDDelivery Order
The Defense Logistics Agency awarded a $14,583.67 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL configurations. This firm fixed-price, competitively awarded delivery order is scheduled for completion by December 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all qualified vendors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp continues to serve as a critical vendor for federal medical procurement needs through its extensive portfolio of competitively awarded contracts with DLA and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 12/10/25 |